Trained as a Chemist, Anne Marinier earned her Ph.D. in Synthetic Organic Chemistry at the Université de Sherbrooke in 1990 after working under the guidance of Pierre Deslongchamps. She then joined Garland Marshall’s team at Washington University School of Medicine, in St. Louis, for a postdoctoral fellowship.
She was hired by pharmaceutical company Bristol-Myers Squibb in 1991. There she worked on developing new anti-infective, anti-inflammatory and anti-tumor drugs. She joined IRIC in 2007 and contributed to the creation of what would become the country’s largest medicinal chemistry group in a university setting. She heads the Institute’s Drug Discovery Unit.